A Randomized, Double-blind, Multicenter, Phase 3 Study of Pelubiprofen Tab. and Celebrex Cap. for Comparative Evaluation of Safety and Efficacy in Rheumatoid Arthritis Patients

Trial Profile

A Randomized, Double-blind, Multicenter, Phase 3 Study of Pelubiprofen Tab. and Celebrex Cap. for Comparative Evaluation of Safety and Efficacy in Rheumatoid Arthritis Patients

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Feb 2013

At a glance

  • Drugs Pelubiprofen (Primary) ; Celecoxib
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Daewon Pharmaceutical
  • Most Recent Events

    • 20 Feb 2013 Actual initiation date (Oct 2010) added as reported by ClinicalTrials.gov.
    • 08 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top